Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

PALI stock hub

Palisade Bio, Inc. has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

PALIis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

301.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

PALI

In the news

Latest news · PALI

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.6P50 18.3P75 33.7

Trailing P/En/a

P25 15P50 23.3P75 38.5

ROE-24.5

P25 -106.6P50 -46.9P75 -3.1

ROIC-16.5

P25 -63.1P50 -27.5P75 -0

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All PALI market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

181

Groups with data

Currency

USD

Showing 181 of 181 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001357459
Company name	Palisade Bio, Inc.
Country	United States
Country code	US
Cusip	696389105
Employees	14
Employees Change	6%
Employees Change Percent	75
Enterprise value	$168M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	US6963894026
Last refreshed	2026-05-10
Market cap	$301.4M
Market cap category	Small-Cap
Price	$1.8
Price currency	USD
Sector	Healthcare
Sic	2836
Symbol	PALI
Website	https://www.palisadebio.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-5.57%
FCF yield	-3.6%
P/B ratio	2.22x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Net Income	$-16.8M
Net Income Growth Years	0%
Profit Per Employee	$-1.2M
ROA	-15.54
Roa5y	-61.21
ROCE	-13.92
ROE	-24.52
Roe5y	-4,087.4
ROIC	-16.46

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	136.98%
Cagr3y	-57.82%
Cagr5y	-79.07%
EPS Growth Quarters	8
EPS Growth Years	12
Revenue Growth Years	0x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	$134.3M
Cash	$133.4M
Current Assets	$134.2M
Current Liabilities	$4.6M
Debt	$71,000
Debt Equity	$0
Equity	$129.4M
Interest Coverage	-1,805.6
Liabilities	$5M
Long Term Assets	$123,000
Long Term Liabilities	$328,000
Net Cash	$133.3M
Net Cash By Market Cap	$44.24
Net Cash Growth	1,281.21%
Net Debt Equity	$-1.03
Tangible Book Value	$129.4M
Tangible Book Value Per Share	$0.81
WACC	12.68

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	28.95
Net Working Capital	$-3.7M
Quick ratio	28.83
Working Capital	$129.6M

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-3,830.18%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	136.84%
200-day SMA	1.64
3Y total return	-92.5%
50-day SMA	1.98
50-day SMA vs 200-day SMA	50over200
5Y total return	-99.96%
All Time High	8,182.5
All Time High Change	-99.98%
All Time High Date	2021-04-28
All Time Low	0.53
All Time Low Change	239.62%
All Time Low Date	2025-09-11
ATR	0.18
Beta	1.53
Beta1y	-0.35
Beta2y	-0.12
Ch YTD	-23.4
High	1.99
High52	2.86
High52 Date	2026-04-22
High52ch	-36.95%
Low	1.8
Low52	0.53
Low52 Date	2025-09-11
Low52ch	239.62%
Ma50ch	-9.23%
Premarket Change Percent	-1.21
Premarket Price	$1.97
Premarket Volume	9,768
Price vs 200-day SMA	10.02%
RSI	41.24
RSI Monthly	7.73
RSI Weekly	49.81
Sharpe ratio	1.23x
Sortino ratio	2.41
Total Return	-3,830.18%
Tr YTD	-23.4
Tr1m	-5.76%
Tr1w	-9.55%
Tr3m	9.76%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	7
Analyst Count Top	3
Analyst Price Target Top	$6.33
Analyst Ratings	Strong Buy
Analyst Ratings Top	Strong Buy
Earnings EPS Estimate	$-0.04
Operating Income	$-18.1M
Price target	$11.29
Price Target Change	$527
Price Target Change Top	$252

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	123,810,802%
Float Percent	73.95%
Net Borrowing	-320,000
Shares Insiders	0.03%
Shares Institutions	57.71%
Shares Out	167,424,202
Shares Qo Q	2,650.55%
Shares Yo Y	3,830.18%
Short Float	20.71%
Short Ratio	5.98
Short Shares	15.31

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-14.8M
Average Volume	4,354,543.4x
Bv Per Share	0.81
Ch1m	-5.76
Ch1w	-9.55
Ch1y	136.8
Ch3m	9.76
Ch3y	-92.5
Ch5y	-99.96
Ch6m	7.14
Change	-9.55%
Change From Open	-9.09
Close	1.99
Days Gap	-0.5
Depreciation Amortization	3,000
Dollar Volume	5,467,858.2
Earnings Date	2026-05-11
Earnings Time	amc
EBIT	$-18.1M
EBITDA	$-18.1M
EPS	$-0.3
F Score	2
FCF	$-10.8M
FCF EV Yield	-6.45x
FCF Per Share	$-0.06
Financing CF	134,440,000
Fiscal Year End	December
Founded	1,996
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-03-20
Last Report Date	2025-12-31
Last Split Date	2024-04-08
Last Split Type	Reverse
Last10k Filing Date	2026-03-20
Ma150	1.91
Ma150ch	-5.91%
Ma20	2.14
Ma20ch	-15.77%
Net CF	123,593,000
Next Earnings Date	2026-05-22
Open	1.98
Optionable	No
Position In Range	0
Post Close	1.8
Postmarket Change Percent	0.56
Postmarket Price	$1.81
Pre Close	1.99
Price Date	2026-05-08
Ptbv Ratio	2.33
Relative Volume	0.7x
Share Based Comp	3,955,000
Tr6m	7.14%
Us State	Colorado
Volume	3,037,699

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does PALI pay a dividend?

Capital-return profile for this ticker.

Performance

PALI stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns PALI?

Insider, institutional, and short-interest positioning.

Institutional ownership

+57.7%

Float: +74.0% of shares outstanding

Insider ownership

+0.0%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

PALI momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.2

Neutral momentum band

Price vs 200-day MA

+10.0%

50/200-day relationship not available

Beta (5Y)

1.53

More volatile than the market

Sharpe ratio

1.23

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About PALI

Hub-level FAQ points readers to the deeper analysis pages.

What is the current PALI stock rating?

Palisade Bio, Inc. is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full PALI analysis?

The full report lives at /stocks/PALI/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for PALI?

The latest report frames PALI around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the PALI page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.